The European Union's pioneering AI Act, poised to dramatically alter the landscape of healthcare and life sciences across Europe, shines a spotlight on the urgent need for compliance among companies involved in AI applications from production to clinical operations. As the regulation drives
With the introduction of major new health insurance reforms in Illinois, patients are poised to experience significant changes in their access to and quality of health care services. The recently signed measures—House Bill 5395 and House Bill 2499—aim to correct some of the most contentious pra
In an era marked by rapid advancements in medical technology, ensuring the safety and efficacy of medical devices remains paramount. The Food and Drug Administration (FDA) has been working diligently on developing a postmarket surveillance system, driven by a 2012 federal law aimed at reducing the
The U.S. pharmaceutical sector faces a critical juncture. With a heavy reliance on Chinese manufacturing for generic drugs and active pharmaceutical ingredients (APIs), the industry finds itself vulnerable. The BIOSECURE Act aims to address these vulnerabilities by reducing or eliminating
Gender bias in medical research has deep historical roots and continues to impact the health outcomes of women today. By understanding this complex issue, we can appreciate the importance of inclusive research practices and explore the steps needed to create a healthcare system that serves everyone
